Kristopher Perkin, Ph.D.
About Kristopher Perkin, Ph.D.
Kristopher Perkin, Ph.D., is a Scientist Fellow at Alkermes with extensive experience in drug product development and regulatory affairs.
Current Role at Alkermes
Kristopher Perkin currently serves as a Scientist Fellow at Alkermes. In this role, he provides technical oversight for all aspects of drug product development. He is responsible for leading the drug product team involved in solid dosage formulation, process, and analytical development, as well as scale-up activities prior to commercial manufacture.
Previous Positions at Alkermes
Kristopher Perkin has held multiple positions at Alkermes over the years. He served as Principal Scientist from 2018 to 2021, Senior Scientist from 2014 to 2018, and Scientist from 2012 to 2014. During these times, he was responsible for various aspects of drug product development, including formulation, analytical development, and regulatory filings.
Work Experience at Elan Pharmaceuticals
Before joining Alkermes, Kristopher Perkin worked at Elan Pharmaceuticals. He was a Formulation Scientist/Senior Formulation Scientist from 2008 to 2012 and a Research Associate II from 2006 to 2008. His work focused on drug formulation and development, contributing to his extensive experience in the pharmaceutical industry.
Educational Background
Kristopher Perkin earned his Ph.D. in Chemistry from the University of Bristol, where he studied from 2003 to 2006. He also holds a Ba.Mod. in Natural Sciences from Trinity College, Dublin, where he studied from 1999 to 2003. Additionally, he completed his Leaving Certificate at Ashton School in Blackrock, Cork City.
Patents and Regulatory Responsibilities
Kristopher Perkin is a named inventor on three patents covering two marketed drug products, including a long-acting injectable and a delayed-release solid oral dosage product. He reviews and approves all IND/IMPD and NDA CMC sections (Module 3) for regulatory filings to support product marketing approval. He also prepares for manufacturing site pre-approval inspections and regulatory audits.